BioSpace News Archive

Shorla Pharma Limited, a specialty pharmaceutical company, announces the appointment of Chief Commercial Officer Nicholas Holsman, a highly experienced U.S. industry executive with in-depth experience in scaling oncology & specialty pharma enterprises.

Long-term care facilities have been disproportionately burdened by COVID-19, accounting for about 60% of COVID-19 deaths nationwide, 70% if retirement homes are included.

Beam Dental, a digital-first dental insurer that rewards its members for good dental hygiene, announced it has raised $80 million in an oversubscribed Series E fundraise.

Theravance Biopharma, Inc., a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will participate in a pre-recorded Fireside Chat at the H.C.

U.S. Food and Drug Administration (FDA) has stated that it does not intend to hold an advisory committee meeting to discuss this application

Study Reveals the Utility of Cyan Fluorescence to Reliably Predict Pseudomonas, a Bacterial Pathogen that Precludes Wound Healing and Often Evades Conventional Treatment Methods

Axonics Modulation Technologies, Inc., a global medical technology company that has developed and is commercializing novel products for the treatment of bladder and bowel dysfunction, announced it has entered into a strategic alliance with Micro Systems Technologies, a leading manufacturer of medical microelectronics.

Solaris Health Holdings, LLC is pleased to announce that Chicago-based Associated Urological Specialists has joined as an affiliated practice.

Aurinia Pharmaceuticals Inc. announced that members of the executive management team will participate in multiple upcoming investor conferences

Itamar Medical Ltd., a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders, reported unaudited financial results for the fourth quarter and full year 2020 and provided full year 2021 guidance.